Improving Cardiometabolic Health in Adolescent Girls With Elevated Anxiety: Web-Based Multisite, Pilot, and Feasibility Randomized Controlled Trial
JMIR Cardio · 17.09.2026 · 10 · e82781-e82781
DOI: 10.2196/82781 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JMIR Cardio, online erschienen am 17.09.2026. Verfasst von Caitlin Edwards und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Development and Family Studies, College of Health and Human Services, Colorado State University, 410 W. Pitkin St, 1570 Campus De…. Hauptthemen laut MEDLINE: Anxiety, Cognitive Behavioral Therapy. Die Arbeit nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Anxiety is common in adolescents with elevated BMI (kg/m 2 ), affecting 33%‐43% of adolescents with overweight or obesity (age- and sex-specific BMI ≥85th percentile ). Anxiety has been associated with poorer cardiometabolic health, and disinhibited eating in response to anxiety may be a key explanatory mechanism. Therefore, reducing anxiety in adolescents may improve disinhibited eating patterns and prevent worsening cardiometabolic health.
Objective
This pilot study primarily aimed to assess the feasibility and acceptability of 2 virtual group psychological interventions, interpersonal psychotherapy (IPT) and cognitive behavioral therapy (CBT), in adolescent girls with elevated anxiety and above-average weight. Secondary aims were to describe changes in anxiety, eating behavior, and cardiometabolic health indices.
Methods
This 2-site, 2-year, pilot and feasibility randomized controlled trial enrolled 12‐ to 17-year-old girls with elevated anxiety symptoms (State-Trait Anxiety Inventory for Children total score ≥32) and above-average weight (BMI ≥75th percentile for age and sex), who were in good general health and not concurrently receiving therapy or medication treatment. Girls were randomly assigned to 1 of 2 web-based arms: 12-week, psychologist-led, group IPT or CBT. In both arms, groups of 5‐7 adolescents met for 90 minutes on secure Zoom (Zoom Communications, Inc) once per week. Anxiety, disinhibited eating, BMI indices, blood pressure, lipids, hemoglobin A 1c (HbA 1c ), and fasting glucose were measured at baseline, 12-week follow-up, and 1-year follow-up. Feasibility of recruitment, retention, and study protocol, and acceptability and fidelity of IPT and CBT were evaluated.
Results
Of 47 eligible adolescents, 40 (85%) enrolled. Enrollment of the total sample (n=40) was completed in 7 months. Retention was 85% (n=17) in IPT and 100% (n=20) in CBT at 12-week follow-up. Protocol adherence exceeded 96% for all intervals. Missing data varied, with higher rates for phlebotomy (up to 30%). Acceptability ratings were above-average for likability (mean 3.03, SD 1.14) and credibility (mean 3.26, SD 0.75; 0‐4 scale with 4=Highest) across arms. Most adolescents received ≥80% intervention dosage (IPT: 90%, CBT: 95%). Expert fidelity ratings of IPT were 78% (SD 11%) and CBT were 94% (SD 9%). From baseline to 1-year, IPT demonstrated improvements in general anxiety (95% CI −8.95 to −1.40), social anxiety (95% CI −12.37 to −1.88), and HbA 1c (95% CI −0.48 to −0.23); CBT demonstrated improvement in emotional eating (95% CI −1.18 to −0.18), and both arms demonstrated improvements in BMI percentile (effect sizes=−0.82 and −0.63, IPT and CBT, respectively).
Conclusions
This pilot and feasibility trial provided initial support for the feasibility of recruitment and retention and acceptability of web-based group IPT and CBT, as well as yielded areas for optimizing protocol feasibility and intervention fidelity. These preliminary results inform the planning of larger-scale efficacy trials with powered samples to assess effects on BMI and cardiometabolic health indicators among adolescents with elevated anxiety and above-average weight.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Human Development and Family Studies, College of Health and Human Services, Colorado State University, 410 W. Pitkin St, 1570 Campus Delivery, Fort Collins, CO, 80523, United States, 1 970-491-3217.
- Endocrinology, Department of Pediatrics, University of Colorado Anschutz Medical Campus and Children's Hospital Colorado, Aurora, CO, United States.
- Department of Psychiatry, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY, United States.
- Department of Medicine, Military and Cardiovascular Outcomes Research (MiCOR), Uniformed Services University of the Health Sciences, Bethesda, MD, United States.
- The Metis Foundation, San Antonio, TX, United States.
- University of Colorado Anschutz Medical Campus, 6Barbara Davis Center for Diabetes, Aurora, CO, United States.
Zitieren
APA
Edwards, C., Ranzenhofer, L., Lavender, J., Gulley, L. D., Aichele, S., Thorstad, I., Sanchez, N., Schrag, R., Sinkford, Z., Emerick, J., Thomas, V., Arnold, T., Young, J., Wilfley, D., Haigney, M., Shomaker, L., & Tanofsky-Kraff, M. (2026). Improving Cardiometabolic Health in Adolescent Girls With Elevated Anxiety: Web-Based Multisite, Pilot, and Feasibility Randomized Controlled Trial. JMIR Cardio, 10, e82781-e82781. https://doi.org/10.2196/82781
Vancouver
Edwards C, Ranzenhofer L, Lavender J, Gulley LD, Aichele S, Thorstad I, et al. Improving Cardiometabolic Health in Adolescent Girls With Elevated Anxiety: Web-Based Multisite, Pilot, and Feasibility Randomized Controlled Trial. JMIR Cardio. 2026;10:e82781-e82781. doi:10.2196/82781
BibTeX
@article{Edwards2026,
author = {Edwards, Caitlin and Ranzenhofer, Lisa and Lavender, Jason and Gulley, Lauren D and Aichele, Stephen and Thorstad, Isabel and Sanchez, Natalia and Schrag, Ruby and Sinkford, Zoe and Emerick, Jill and Thomas, Victoria and Arnold, Thomas and Young, Jami and Wilfley, Denise and Haigney, Mark and Shomaker, Lauren and Tanofsky-Kraff, Marian},
title = {Improving Cardiometabolic Health in Adolescent Girls With Elevated Anxiety: Web-Based Multisite, Pilot, and Feasibility Randomized Controlled Trial},
journal = {JMIR Cardio},
year = {2026},
volume = {10},
pages = {e82781--e82781},
doi = {10.2196/82781}
}
EUVIMED